These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 286124)

  • 1. Complement-dependent cytotoxic antitumor antibody. II. Quantitative determination of cell-bound immunoglobulin M1.
    Boyle MD; Langone JJ
    J Natl Cancer Inst; 1979 Jun; 62(6):1537-44. PubMed ID: 286124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of antibody-complement-mediated killing of tumor cells by hormones.
    Schlager SI; Ohanian SH; Borsos T
    Cancer Res; 1976 Oct; 36(10):3672-7. PubMed ID: 182362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysis of tumor cells by antibody and complement. II. Lack of correlation between amount of C4 and C3 fixed and cell lysis.
    Ohanian SH; Borsos T
    J Immunol; 1975 Apr; 114(4):1292-5. PubMed ID: 163862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of surface-bound antibody accompanying the anti-complementary modulation of leukemic B cell immunoglobulin: contrasting effects of antibodies directed against idiotypic and constant regions.
    Gordon J; Anderson VA; Stevenson GT
    J Immunol; 1982 Jun; 128(6):2863-9. PubMed ID: 6804570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between the ability of tumor cells to incorporate specific fatty acids and their sensitivity to killing by a specific antibody plus guinea pig complement.
    Schlager SI; Ohanian SH; Borsos T
    J Natl Cancer Inst; 1978 Sep; 61(3):931-4. PubMed ID: 278869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemolytic efficiency of cell-bound IgM: evidence that IgM-C1 complexes activate C4 molecules not hemolytic with homologous C2--C9.
    Ejzemberg R; Borsos T
    J Immunol; 1982 Apr; 128(4):1600-2. PubMed ID: 7061844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of measles virus-specific cytotoxic antibodies by use of a chronically infected cell line.
    Ehrnst AC
    J Immunol; 1975 Mar; 114(3):1077-82. PubMed ID: 1089724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediation of cytotoxic functions by classes and subclasses of sheep antibody reactive with cell surface immunoglobulin idiotypic and constant region determinants.
    Stevenson FK; Elliott EV
    Immunology; 1978 Feb; 34(2):353-8. PubMed ID: 75184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New monoclonal antibodies specific for the guinea pig line 10 hepatocarcinoma.
    Kataoka T; Chiba J; Ohnuki T; Nemoto K; Tokunaga T
    Jpn J Cancer Res; 1987 Sep; 78(9):960-7. PubMed ID: 3117752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement receptor lymphocytes. Analysis of immunoglobin on their surface and further evidence of heterogeneity.
    Arnaiz-Villena A; Hay FC
    Immunology; 1975 Apr; 28(4):719-29. PubMed ID: 1097333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forssman antigen content of guinea pig hepatomas induced by diethylnitrosamine: a quantitative approach to the search for tumor-specific antibodies.
    Crisler C; Rapp HJ; Weintraub RM; Borsos T
    J Natl Cancer Inst; 1966 Mar; 36(3):529-38. PubMed ID: 18630327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunochemical quantitaion of the third component of guinea pig complement in fluid phase and bound to cell surfaces.
    Ohanian SH; Borsos T
    J Immunol; 1975 Jan; 114(1 Pt 2):326-30. PubMed ID: 1167878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement receptor lymphocytes in the rabbit I. an SIg-negative subpopulation in the appendix.
    Green WR; Fanger MW
    J Immunol; 1976 Nov; 117(5 Pt.2):1805-11. PubMed ID: 993581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of anti-IgM and growth factor-induced proliferation of guinea pig B cells by one of two distinct Fc gamma receptors on the cells.
    Yamashita T; Koyama J
    J Immunol; 1988 Nov; 141(9):2889-94. PubMed ID: 2971734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergy between IgG and monoclonal IgM antibodies in antibody-dependent cell cytotoxicity.
    Shen L; Lydyard PM; Roitt IM; Fanger MW
    J Immunol; 1981 Jul; 127(1):73-8. PubMed ID: 6787133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral immune killing of nucleated cells: mechanisms of complement-mediated attack and target cell defense.
    Ohanian SH; Schlager SI
    Crit Rev Immunol; 1981 Jan; 1(3):165-209. PubMed ID: 6174273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some effects on leukaemic B lymphocytes of antibodies to defined regions of their surface immunoglobulin.
    Stevenson FK; Elliott EV; Stevenson GT
    Immunology; 1977 Apr; 32(4):549-57. PubMed ID: 415966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane-bound immunoglobulins on human leukemic cells. Evidence for humoral immune responses of patients to leukemia-associated antigens.
    Metzgar RS; Mohanakumar T; Miller DS
    J Clin Invest; 1975 Aug; 56(2):331-8. PubMed ID: 807598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysis of tumor cells by antibody and complement. III. Lack of correlation between antigen movement and cell lysis.
    Boyle MD; Ohanian SH; Borsos T
    J Immunol; 1975 Aug; 115(2):473-5. PubMed ID: 50364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.